Search
for
Sort by
Research 301–330 of 1000+
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- What’s new in the treatment of hair loss?
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Hormone therapy in acne
- Targets to treat androgen excess in polycystic ovary syndrome
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- General Dermatology
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Dermatologic Reactions to Targeted Therapy
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Pharmacological Treatment of Alopecia
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Alopecia Areata and Alopecia Areata Incognita
- Hormonal treatment of acne vulgaris: an update
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2